Medical Support
Regenerative medicine is a medical treatment that aims to improve functions that have been lost due to injury or disease by utilizing the "regenerative power (cells)" of the human body.
The market scale of regenerative medicine is said to reach 2.5 trillion yen in Japan and 38 trillion yen in the world by 2050. In proportion to the scale of this market, social issues in Japan (especially in the medical field) will inevitably become even more serious.
To address these major issues, we will combine the SBC Group's proprietary technological capabilities with the "power to spread the word" that we have cultivated to solve social issues.
In order to make truly valuable products more accessible and familiar to our customers, we are working with SBC to develop services and provide them to each clinic.
PRP (platelet-rich plasma) contained in the blood of patients entrusted to us by medical institutions is extracted and filtered with growth factors that have self-healing and anti-inflammatory effects. (Poly Platelet Plasma), which is contained in the patient's blood, is further extracted and filtered with growth factors that have self-healing and anti-inflammatory effects, and injected into the area of concern to improve the function of the area. This adjustment method is the SBC Group's proprietary technological capability.
This is a contract processing service to extract and culture adipose-derived stem cells from patients' adipose tissue received from medical institutions. After culturing, the cells are frozen for long-term storage at our company.